Skip to main content

Table 3 Clinical Characteristics at Presentation

From: Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series

Feature

All

Ala97Ser

Phe64Leu

Ser77Tyr

Val30Met

Other

Any Reported

374 (69%)

35 (9%)

22 (6%)

48 (13%)

141 (38%)

128 (34%)

Autonomic

199 (53%)

27 (77%)

18 (82%)

5 (10%)

74 (52%)

75 (59%)

 Unspecified

47

0

7

1

22

17

 Urinary

36

7

3

0

16

10

 Gastrointestinal

114

22

6

3

39

44

 Cardio

96

15

7

1

34

39

 Respiratory

3

0

0

0

0

3

 Impotence

51

18

5

1

13

14

 Sweat

20

7

3

1

4

5

Sensory

326 (87%)

25 (71%)

22 (100%)

45 (94%)

127 (90%)

107 (84%)

 Unspecified

76

21

5

0

25

25

 Lower Limbs

219

2

15

37

100

65

 Upper Limbs

133

2

10

35

48

38

 Carpal Tunnel

42

4

4

0

7

27

Motor

215 (57%)

10 (29%)

15 (68%)

32 (67%)

79 (56%)

79 (62%)

 Unspecified

67

9

4

0

33

21

 Lower Limbs

138

0

11

28

46

53

 Upper Limbs

83

1

10

10

33

29

 Other

1

0

0

0

0

1

Miscellaneous

155 (41%)

4 (11%)

17 (77%)

14 (29%)

39 (28%)

81 (63%)

 Cardiomyopathy

93

4

15

2

28

44

 Visual (Non-Motor)

49

0

2

13

9

25

 Weight Loss

35

0

2

2

9

22

  1. Specific genotypes shown are those with ≥4% representation among the included cases. Genotypes with < 4% representation are listed as “Other”. Refer to Additional file 1: Appendix A for a list of genotypes included in the “Other” category